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The inner ear was previously assumed to be an “immune-privileged” organ due to the
existence of its tight junction-based blood-labyrinth barrier. However, studies performed
during the past decade revealed that the mesenchymal region of the cochlea, including its
lateral wall, is a common site of inﬂammation. Neutrophils do not enter this region, which
is consistent with the old dogma; however, bone marrow-derived resident macrophages
are always present in the spiral ligament of the lateral wall and are activated in response
to various types of insults, including noise exposure, ischemia, mitochondrial damage,
and surgical stress. Recent studies have also revealed another type of immune cell,
called perivascular melanocyte-like macrophages (PVM/Ms), in the stria vascularis. These
dedicated antigen-presenting cells also control vascular contraction and permeability. This
review discusses a series of reports regarding inﬂammatory/immune cells in the cochlear
lateral wall, the pathways involved in cochlear damage and their potential as therapeutic
targets.
Keywords: inner ear, cochlea, hearing loss, inflammation, immune response, cochlear macrophage, perivascular
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INTRODUCTION
The cochlea is the end organ of the auditory system and is
responsible for transducing sound stimuli into a nerve impulse.
Sound from the environment travels as a wave through a
medium (e.g., air, water) and is conducted through the ossic-
ular chain of the middle ear; the mechanical vibration of the
bones is converted to a compression wave in the inner ear ﬂuid,
which vibrates a structure in the cochlea called the organ of
Corti. The hair cells at the top of the organ of Corti con-
vert the physical mechanical movement into action potentials
through their mechanotransduction channels, and this sig-
nal is transferred to the brain via bipolar auditory neurons.
Through this process, this spiral-shaped, ﬂuid-ﬁlled organ located
deep in the temporal bone transmits middle ear mechanics
to the central nervous system (CNS; LeMasurier and Gillespie,
2005).
Non-sensory cells in the cochlea are assumed to play an impor-
tant role in generating the conductance of the cochlea for the
electrophysiological activity of hair cells (Hibino and Kurachi,
2006). Differences in ion concentrations between partitions in
the cochlea and the endocochlear potential in the endolymph
are required for the mechanotransduction channels on the hair
cells to generate an action potential. The mesenchymal cells in
the spiral ligament of lateral wall, the spiral limbs and the epithe-
lial cells in the stria vascularis are the sources of conductance via
the ATP-dependent activity of ion pumps (Hibino and Kurachi,
2006; Guinan et al., 2012). In contrast to the avascular organ of
Corti, the lateral wall, and spiral limbs are known for their “vas-
cular rich” environment, and researchers have assumed that the
microvessels in the area form an essential source of water and
ions. The concept is similar to the situation in the kidney, another
organ that is exposed to the outer environment and is responsible
for the maintenance of ﬂuid homeostasis: the spaces are sepa-
rated by tight junctions, and ions are constantly recycled between
partitions.
By contrast, the inner ear, including the cochlea, was assumed
to be an immune-privileged organ, similar to the eyes or brain,
due to the existence of tight junctions (McCabe, 1989). In this
context, this tight junction-based structure in the stria vascu-
laris is called the “blood-labyrinth barrier,” and it is believed
that the barrier blocks immune cells, inner ear antigens, and
antibodies (Harris, 1983, 1984). This concept explains immune-
mediated hearing loss or autoimmune inner ear disorders. Due
to the barrier, the systemic immune system cannot recognize
inner ear antigens, and when these antigens are released due to
insult-induced damage to the barrier, the immune system inap-
propriatelymounts an attack on the“foreign”antigen (Harris et al.,
1985).
Decades have passed since the dogma of immune privilege was
established, and several lines of evidence have revealed two cell
types of macrophage lineage in the lateral wall of the cochlea:
“cochlear macrophages” in the spiral ligament and “perivascular
macrophage-like melanocytes (PVM/Ms)” in the stria vascularis
(Zhang et al., 2012). The spiral ligament is indeed a common site
of inﬂammation, and cochlear macrophages are responsible for
these inﬂammatory responses for communication with spiral lig-
ament ﬁbrocytes (Hirose et al., 2005). The stria vascularis is, as
mentioned above, the site of tight junctions, and the PVM/Ms
are responsible for controlling the permeability of the barrier
when inﬂammatory/immune responses are induced by the local
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release of inﬂammatory cytokines or chemokines (Zhang et al.,
2012).
This article describes a series of reports from the litera-
ture regarding those macrophage-like cells, including reports
on their roles in inﬂammatory/immune responses and the
maintenance of cochlear homeostasis. Additionally, this arti-
cle describes gene expression networks in the lateral wall
that are activated in response to damage. Potential uses of
those cells and signals as therapeutic targets are also dis-
cussed.
IMMUNE CELLS/INFLAMMATORY CELLS IN THE COCHLEA
COCHLEAR MACROPHAGES
Overexposure to intense noise is a well-known cause of hear-
ing impairment both clinically and experimentally. After decades
of investigations on the detailed pathophysiology of hair cells,
researchers began to direct their attention to the phenomena
occurring in the non-sensory region during and after noise
trauma. Wang and Hirose precisely documented the histopathol-
ogy of the non-sensory region of the cochlea, including its lateral
wall spiral ligament, stria vascularis, and spiral limbs, during
noise-induced hearing loss in mice. They reported the loss of
ﬁbrocytes, the degeneration of stria cells and the partial recov-
ery of ﬁbrocytes after overexposure to noise (Wang et al., 2002;
Hirose and Liberman, 2003).
Early electronmicroscopy studies of thenoise-damaged cochlea
reported the presence of inﬂammatory cells (Fredelius and Rask-
Andersen, 1990; Fredelius et al., 1990), but quantitative analyses
and close examination of the roles of those cells were not per-
formed due to technological limitations. In the early 2000s,
research tools for investigating inﬂammatory and/or immune
responses were extensively developed and were applied in var-
ious organs. These tools were not used only in normal tissue;
researchers began to investigate lesions in various parts of the
body, including the CNS, such as ischemic or traumatized brains
(Hu et al., 2014). Antibodies labeling speciﬁc linages were used,
and numerous genetically engineered knockout or transgenic
mice were developed. Protocols for sorting particular lineages
of hematopoietic stem cells or bone marrow mesenchymal cells
became well-established, and bonemarrow transplantation to fol-
low the lineage in vivo became popular among immunologists
(Hess et al., 2004).
The distribution of immune cells and inﬂammatory responses
in the cochlea after ototoxic insults was examined by several
groups. Those reports indicated that the mesenchymal region is
a common site of inﬂammation. Hirose et al. (2005) revealed the
inﬁltration of CD45+ Iba1+ CX3CR1+ cells in the cochlea after
noise exposure, and they called the cells “cochlear macrophages.”
Lang et al. (2006) showed that the cells were positive for CD11b,
CD68, ED1, and PKC-βII and that the cells derived from
bone marrow cells. Okano et al. (2008) showed that the num-
ber of cochlear macrophages increased after sham surgery and
that the turnover time of cochlear macrophages in mice was
longer than 6 months. Although the precise roles of cochlear
macrophages remain unclear, morphological observations suggest
that cochlear macrophages clear dead or dying cells by phagocy-
tosis (Hirose et al., 2005). Speciﬁc ablation of a particular lineage
at crucial timepoints using a genetically modiﬁed mouse would
provide a mechanism for determining the role of inﬂammatory
cells.
Other roles have been proposed for the macrophages in the
lateral wall spiral ligament. Shi and her colleagues have shown
that the macrophages in the type V ﬁbrocyte region, around the
junction of Reissner’smembrane and the lateral wall, were coupled
to microvessels and contributed to the liquid ﬂow by inducing
vasospasms in response to noise insults (Dai and Shi, 2011). The
decrease in blood ﬂow in the lateral wall during and after noise
exposure has long been known, but the underlying mechanics
were not fully elucidated until that work was published. The new
ﬁndings may produce another future therapeutic target for noise-
induced hearing loss.
PERIVASCULAR MELANOCYTE-LIKE MACROPHAGES
Perivascular resident macrophages (PVMs) are macrophages that
exist in many tissues, including the brain and retina (Cuadros
and Navascues, 1998; Hess et al., 2004). In each organ, PVMs
are closely associated with microvessels and intertwined with
endothelial cells, and they express common macrophage mark-
ers such as F4/80, CD68, CD11b, and MHC class II (Shi,
2010). The known roles of PVMs include immunologic defense
and tissue repair. Individual cells remain in place for a long
period, but after damage, new cells are recruited from bone
marrow, producing turnover at the site of damage (Hess et al.,
2004).
The lateral wall stria vascularis is another spiral-shaped “vas-
cular rich” part of the cochlea. This structure is composed
of three layers of cells, marginal cells, intermediate cells and
basal cells, and capillaries are distributed between the layers
(Hibino and Kurachi, 2006). Tight junctions in the stria vas-
cularis establish compositionally distinct ﬂuid compartments.
Homeostasis among the endolymph, perilymph, and circulat-
ing serum in the capillaries is maintained properly due to this
structure.
The presence of melanocytes in this region has been known
for two decades (Masuda et al., 1994), but their role was not fully
understood. In the early 2010s, marker studies using antibodies
similar to thosementioned above showed the presence of immune
cells or inﬂammatory cells with the features of melanocytes. Again,
Shi and her colleagues found that F4/80+ GST+ melanocyte-
like macrophages are always present in the perivascular region
of the stria vascularis (Zhang et al., 2012). The cells were observed
on the surface of endothelial cells in the stria region, suggesting
that the immune cells are coupled with microvessels and con-
trol the integrity of the blood-labyrinth barrier. Indeed, they
demonstrated that the depletion of PVM/Ms achieved by gene
targeting produced leaky capillaries and elevated hearing thresh-
olds in vivo, demonstrating that these cells are indispensable
for the maintenance of cochlear ﬂuid homeostasis (Zhang et al.,
2012).
Numerous reports, both experimental and clinical, have shown
the occurrence of hydrops in immune-mediated inner ear dis-
orders, but the molecular and cellular mechanisms of hydrops
remain to be elucidated. Although there is not yet any direct
evidence, the roles of PVM/Ms in the control of ﬂuid exchange
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with the systemic circulation in response to immune-mediated
or inﬂammatory responses may account for the above-mentioned
phenomenon.
INFLAMMATORY/IMMUNE-RELATED GENE EXPRESSION IN
THE DAMAGED COCHLEA
GENE EXPRESSION PROFILING OF THE LATERAL WALL AFTER
COCHLEAR DAMAGE
Omics biology is a powerful approach for obtaining a compre-
hensive understanding of local phenomena occurring in diseases.
Several microarray analyses have been performed in the cochlea
after insults. Vazquez and colleagues examined the gene expres-
sion proﬁle in the whole mouse cochlea 6 h after noise expo-
sure and showed the upregulation of immune genes including
CXCL10, SOCS3, Ifrd1, Iﬁ202b, Igh-6, and TCl1b1 (Gratton et al.,
2011). Wangemann’s group reported the expression of numer-
ous inﬂammatory/immune-related genes in the stria vascularis
and revealed an increase in genes associated with macrophages
and dendritic cells, including CD68 and MHC class II genes,
in the stria vascularis of Slc26a4 knockout mouse (Jabba et al.,
2006). They also showed higher numbers of pigmented cells
in the knockout mouse than in the littermate control (Jabba
et al., 2006). In addition, we reported increased expression of
numerous inﬂammatory genes in the lateral wall spiral ligament
after 3NP-induced acutemitochondrial dysfunction (Fujioka et al.,
2014). Collectively, these reports demonstrate the presence of
inﬂammatory/immune cells and their involvement in the cochlear
damage.
INFLAMMATORY CYTOKINES OR CHEMOKINES
In general, proinﬂammatory cytokines are among the ﬁrst genes
upregulated in response to insults at sites of inﬂammation. These
cytokines are produced in various organs after tissue damage in
experimentalmodels of the immune response, infection, ischemia,
trauma, cryo-ablation, and burns (Berti et al., 2002; Pier et al.,
2004), and they are produced by various cell types, including
residential immune-related cells (e.g., leukocytes, macrophages,
microglia, dendritic cells) and neurons and glia in the CNS. The
signaling downstream from proinﬂammatory cytokines includes
the attraction and activation of immune cells, including leukocytes
and macrophages.
Because cytokine signals are transmitted to target cells in
an autocrine/paracrine manner, the blockade of signals using
an antagonist or antibody preparation can be used as a new
therapeutic, as demonstrated by the use of inﬂiximab, etaner-
cept, or tocilizumab in inﬂammatory diseases (Nishimoto and
Kishimoto, 2006; Willrich et al., 2014). Therefore, understand-
ing the behavior and the physiological and pathophysiologi-
cal roles of inﬂammatory cytokines is critical for translational
research into the diseases of each organ, presumably including
the cochlea.
INFLAMMATORY CYTOKINES OR CHEMOKINES INVOLVED IN
IMMUNE-MEDIATED HEARING LOSS
The in vivo production of TNF-α, IL-1β, and IL-6 in the
cochlea, along with synergic leukocyte inﬁltration, has been
described in experimental studies of inner ear inﬂammation
(Satoh et al., 2003; Hashimoto et al., 2005). In this model, the
researchers ﬁrst sensitized the animals using an intraperitoneal
injection of an antigen, keyhole limpet hemocyanin (KLH).
Next, they surgically injected KLH into the cochlea. In those
animals, an immune response occurred in the cochlea, includ-
ing the recruitment of many immune cells. In addition, an
in vivo loss-of-function analysis demonstrated that TNF-α was
a factor that worsened cochlear inﬂammation (Satoh et al.,
2003).
These studies are very important because such molecules
are in general, well-known for their potential to induce sec-
ondary inﬂammatory responses, including leukocyte inﬁltra-
tion, scar formation, and gliosis, in other injured organs.
Based on the results of animal studies, several clinical tri-
als are currently in progress, some of which have preliminary
results. Future therapeutics based on these results may become
available in the near future, although the translation takes
time.
INFLAMMATORY CYTOKINES INVOLVED IN NOISE-INDUCED HEARING
LOSS
The authors’ group ﬁrst reported that proinﬂammatory cytokines,
TNF-α, IL-1β and IL-6, were produced in cochlear ﬁbrocytes
damaged by noise and that the time courses of their expression
levels were very similar to those observed in other traumatized
organs (Fujioka et al., 2006). The blockage of one of these proin-
ﬂammatory cytokines, IL-6, drastically reduced the number of
Iba-1-positive cochlear macrophages, suggesting that the inﬁl-
tration and activation of those immune cells occur in response
to the cytokine (Wakabayashi et al., 2010). Although the effect
of the medication in the noise-damaged mouse was relatively
small, of which amelioration in hearing loss was within 20 dB,
and could only be observed in the apical area, which is in
charge of lower frequency sounds, this result indicates that ther-
apeutics targeting inﬂammatory cytokines or chemokines show
potential.
INFLAMMATORY CYTOKINES AND CHEMOKINES INVOLVED IN ACUTE
MITOCHONDRIAL DYSFUNCTION
A model of acute cochlear mitochondrial dysfunction was gen-
erated by applying an irreversible blocker of mitochondria respi-
ratory complex II onto the round window niche in rats (Hoya
et al., 2004). In this model, severe cell loss occurred in the
lateral wall spiral ligament, usually along with a profound hear-
ing impairment (Okamoto et al., 2005). As described above,
numerous inﬂammatory/immune-related genes were induced
after the insult. Surprisingly, 35 and 60% of the genes show-
ing 2-fold upregulation at 1 and 3 days post-3-NP adminis-
tration, respectively, were inﬂammatory genes, including CC-
and CXC-type chemokine genes (Fujioka et al., 2014). The
high percentage of inﬂammatory genes proved that inﬂamma-
tory/immune reactions occurred at the cochlear lateral wall
ﬁbrocytes. Interestingly, neutrophil receptors were never detected
in the experiment, although their chemokine ligands for the
recruitment of neutrophil were expressed, which is consistent
with the old dogma of immune privilege. The only cell types
that expressed both the receptors and ligands were those of
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the monocyte lineage, and this was also observed in the noise-
exposed murine lateral wall (Hirose et al., 2005). Therefore,
manipulating the pathways of chemokine signals, including the
CCL family, could be used to develop therapeutics targeting
the hearing loss caused by mitochondrial dysfunction in the
inner ear.
CONCLUSION AND FUTURE DIRECTIONS
During the past few decades, accumulating evidence from the
work of several groups in the ﬁeld of inner ear biology has
revealed the presence of the inﬂammatory and immune sys-
tems in the cochlea, phenomena that had been obscured by
the dogma of immune privilege. However, these ﬁndings are
mainly based on models that cannot fully recapitulate clini-
cal cases. For example, in autoimmune inner ear disorders,
the fundamental mechanisms underlying the autoimmunity
remain unknown, although many clinical ﬁndings over the
last 40 years suggest that deafness develops from autoimmu-
nity. Recent ﬁndings have shown the CD4+ T-cell-mediated
immune surveillance in the cochlea (Solares et al., 2004), but
the initial step of the autoimmunity or antigen presentation has
not yet been elucidated in the cochlea, in which a drainage
lymph node has not been found. Therefore, generating new
models using emerging technologies and analyses based on the
information reviewed in this article may explain the remain-
ing mysteries regarding the inﬂammatory/immune systems in the
cochlea.
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